A recent study published in Nature Medicine has revealed that artificial intelligence (AI) can significantly improve breast cancer detection rates. The research, conducted in Germany, found that AI-assisted mammography screening identified one more cancer case per 1,000 screened individuals compared to traditional methods. This breakthrough has the potential to streamline the screening process and reduce…
Researchers have made a groundbreaking discovery linking a gene variant to the spread of breast cancer. The PCSK9 gene, previously known for its role in cholesterol levels, has been found to drive the metastasis of breast cancer. A lab-made antibody, already approved for high cholesterol treatment, has shown promise in reducing cancer spread in mouse…
Scientists have developed an experimental screening method that pairs dogs with artificial intelligence to detect the odor of cancer carried on patients’ breaths. The canine-AI duo was highly accurate and sensitive, successfully spotting four types of cancer in 94% of cases. This breakthrough could lead to earlier cancer detection and increased survival rates. Forecast for…
2024 was a remarkable year for science, with numerous record-breaking discoveries that captivated the world. From the oldest known mid-air explosion to the development of the world’s fastest microscope, scientists made groundbreaking findings that shed new light on the natural world. This article highlights some of the most significant discoveries of the year and provides…
A groundbreaking new tool, FastGlioma, has been developed to detect residual cancerous tissue in brain tumors during surgery. This AI-powered tool uses stimulated Raman histology and artificial intelligence to analyze tissue samples in real-time, providing neurosurgeons with accurate and fast results. FastGlioma has been shown to outperform conventional methods, with a 3.8% tumor miss rate…
Researchers at the University of Iowa and University Medical Center Utrecht have made a significant breakthrough in cancer treatment by incorporating volumetric-modulated arc therapy (VMAT) delivery capabilities into the MR-linac. This innovation could improve plan quality and efficiency, reduce patient discomfort, and make MRI-guided treatments more accessible to patients. The team demonstrated that VMAT deliveries…
A team of researchers from the USA and India has developed a mathematical model to investigate the complex relationship between exercise, immune function, and cancer. The model reveals that increasing exercise intensity and duration leads to greater and sustained tumour suppression, offering valuable insights into how exercise can influence immune responses and potentially guide cancer…
Researchers at New York University have made a groundbreaking discovery that kidney cells can store information and recognize patterns in a similar way to neurons, challenging the long-held notion that memory is exclusive to the brain. The study, published in Nature Communications, found that kidney cells exhibit a “massed-space effect,” a feature of memory that…
Scientists have made a groundbreaking discovery in understanding the human brain’s unique genetic features, which could lead to new therapies for conditions such as Parkinson’s disease and schizophrenia. By comparing human and primate brain cells, researchers found that human dopamine neurons express more genes that boost the activity of damage-reducing antioxidants, allowing them to cope…
The article highlights six antisense oligonucleotide companies leading the way in this emerging field. These companies, including Ionis Pharmaceuticals, Isarna Therapeutics, Regulus Therapeutics, Sarepta Therapeutics, Secarna Pharmaceuticals, and Wave Life Sciences, are developing innovative treatments for various diseases. The global antisense oligonucleotides market is projected to grow significantly, driven by the ability of these treatments…
